Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

Clinical trial NCT04946968 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04946968
Sponsor: National Cancer Centre, Singapore
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumours Non-small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2021-08-24
Primary completion: 2027-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.